The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
The promise and peril of chemical probes
Open accessAbstract
Chemical probes are powerful reagents with increasing impacts on biomedical research. However, probes of poor quality or that are used incorrectly generate misleading results. To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., Reddy, H., Caivano, M., & Cohen, P. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510095 · Cited by 4,366
Self-citationVlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,248
Hidaka, H., Inagaki, M., Kawamoto, S., & Sasaki, Y. (1984) · Biochemistry · doi:10.1021/bi00316a032 · Cited by 2,688
Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinase
Tamaoki, T., Nomoto, H., TAKAHASHI, I., Kato, Y., Morimoto, M., & Tomita, F. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90008-2 · Cited by 2,452
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
Prakasam, T., Matosiuk, D., & Jóźwiak, K. (2013) · Chemical Reviews · doi:10.1021/cr200409f · Cited by 1,933
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Göttlicher, M., Minucci, S., Zhu, P., Krämer, O. H., Schimpf, A., Giavara, S., Sleeman, J. P., Coco, F. L., Nervi, C., Pelicci, P. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,930
Targeting bromodomains: epigenetic readers of lysine acetylation
Filippakopoulos, P., & Knapp, S. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4286 · Cited by 1,298
Self-citationDorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism
Yu, P. B., Hong, C. C., Sachidanandan, C., Babitt, J. L., Deng, D. Y., Hoyng, S. A., Lin, H. Y.-F., Bloch, K. D., & Peterson, R. T. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.54 · Cited by 1,059
Cited by
Sorted by citations
Roth, B. L. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.040 · Cited by 1,742
Self-citationCounting on natural products for drug design
Rodrigues, T., Reker, D., Schneider, P., & Schneider, G. (2016) · Nature Chemistry · doi:10.1038/nchem.2479 · Cited by 1,250
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,228
Opportunities and challenges in phenotypic drug discovery: an industry perspective
Moffat, J. G., Vincent, F., Lee, J. A., Eder, J., & Prunotto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.111 · Cited by 939
Muratov, E. N., Bajorath, J., Sheridan, R. P., Tetko, I. V., Filimonov, D., Poroikov, V., Oprea, T. I., Baskin, I. I., Varnek, A., Roitberg, A., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00098a · Cited by 913
Modern advances in heterocyclic chemistry in drug discovery
Taylor, A. P., Robinson, R. P., Fobian, Y. M., Blakemore, D. C., Jones, L. H., & Fadeyi, O. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob00936k · Cited by 903
Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017─Utility and Limitations
Baell, J. B., & Nissink, J. W. M. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00903 · Cited by 669
Self-citationBaell, J. B. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00947 · Cited by 561
Self-citationEmerging therapeutic opportunities for integrin inhibitors
Slack, R. J., Macdonald, S. J. F., Roper, J. A., Jenkins, G. R., & Hatley, R. J. D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00284-4 · Cited by 558
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
Douangamath, A., Fearon, D., Gehrtz, P., Krojer, T. J., Lukacik, P., Owen, C. D., Resnick, E., Strain-Damerell, C. M., Aimon, A., Ábrányi‐Balogh, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18709-w · Cited by 539
Open Targets Platform: supporting systematic drug–target identification and prioritisation
Ochoa, D., Hercules, A., Carmona, M., Süveges, D., Gonzalez‐Uriarte, A., Malangone, C., Miranda, A., Fumis, L., Carvalho‐Silva, D., Spitzer, M., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1027 · Cited by 487
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Proschak, E., Stark, H., & Merk, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00760 · Cited by 498
Open Targets Platform: new developments and updates two years on
Carvalho‐Silva, D., Pierleoni, A., Pignatelli, M., Ong, C. K., Fumis, L., Karamanis, N., Carmona, M., Faulconbridge, A., Hercules, A., McAuley, E., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1133 · Cited by 453
Bromodomains: a new target class for drug development
Cochran, A. G., Conery, A. R., & Sims, R. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0030-7 · Cited by 450
Protein arginine methylation: from enigmatic functions to therapeutic targeting
Wu, Q., Schapira, M., Arrowsmith, C. H., & Baršytė-Lovejoy, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00159-8 · Cited by 462
Self-citationThe Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization
Pennington, L. D., & Moustakas, D. T. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01807 · Cited by 428
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy
Morera, L., Lübbert, M., & Jung, M. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0223-4 · Cited by 412
A Perspective on the Kinetics of Covalent and Irreversible Inhibition
Strelow, J. M. (2017) · SLAS Discovery · doi:10.1177/1087057116671509 · Cited by 392
Atropisomerism in Medicinal Chemistry: Challenges and Opportunities
Toenjes, S. T., & Gustafson, J. L. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0152 · Cited by 389
Click Chemistry in Proteomic Investigations
Parker, C. G., & Pratt, M. R. (2020) · Cell · doi:10.1016/j.cell.2020.01.025 · Cited by 391
Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride Probes
Zhao, Q., Ouyang, X., Wan, X., Gajiwala, K. S., Kath, J. C., Jones, L. H., Burlingame, A. L., & Taunton, J. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b08536 · Cited by 388
Self-citationThorsell, A. G., Ekblad, T., Karlberg, T., Löw, M., Pinto, A. F., Tresaugues, L., Moche, M., Cohen, M. S., & Schuler, H. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00990 · Cited by 369
Neri, D., & Lerner, R. A. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012550 · Cited by 364
Phenotypic drug discovery: recent successes, lessons learned and new directions
Vincent, F., Nueda, A., Lee, J. L. C., Schenone, M., Prunotto, M., & Mercola, M. A. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00472-w · Cited by 397
The emerging role of mass spectrometry-based proteomics in drug discovery
Meissner, F., Geddes‐McAlister, J., Mann, M., & Bantscheff, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00409-3 · Cited by 373
Illuminating the dark phosphoproteome
Needham, E. J., Parker, B. L., Burykin, T., James, D. E., & Humphrey, S. J. (2019) · Science Signaling · doi:10.1126/scisignal.aau8645 · Cited by 336
Inhibitors of Protein Methyltransferases and Demethylases
Kanıskan, H. Ü., Martini, M. L., & Jin, J. J. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00801 · Cited by 327
Self-citationVasta, J. D., Corona, C. R., Wilkinson, J., Zimprich, C., Hartnett, J. R., Ingold, M. R., Zimmerman, K., Machleidt, T., Kirkland, T. A., Huwiler, K. G., et al. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.10.010 · Cited by 285
Self-citationModulators of 14-3-3 Protein–Protein Interactions
Stevers, L. M., Sijbesma, E., Botta, M., MacKintosh, C., Obšil, T., Landrieu, I., Cau, Y., Wilson, A. J., Karawajczyk, A., Eickhoff, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00574 · Cited by 295
Docking Screens for Novel Ligands Conferring New Biology
Irwin, J. J., & Shoichet, B. K. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b02008 · Cited by 284
Self-citationSchneider, M., Radoux, C. J., Hercules, A., Ochoa, D., Dunham, I., Zalmas, L.-P., Hessler, G., Ruf, S., Shanmugasundaram, V., Hann, M. M., et al. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00245-x · Cited by 273
Jost, M., Chen, Y., Gilbert, L. A., Horlbeck, M. A., Krenning, L., Menchon, G., Rai, A., Cho, M. Y., Stern, J. J., Prota, A. E., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.012 · Cited by 244
Frost, J., Galdeano, C., Soares, P., Gadd, M. S., Grzes, K. M., Ellis, L. C. J., Epemolu, O., Shimamura, S., Bantscheff, M., Grandi, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms13312 · Cited by 247
Maniaci, C., Hughes, S. J., Testa, A., Chen, W., Lamont, D. J., Rocha, S., Alessi, D. R., Romeo, R., & Ciulli, A. (2017) · Nature Communications · doi:10.1038/s41467-017-00954-1 · Cited by 245
Improving target assessment in biomedical research: the GOT-IT recommendations
Emmerich, C. H., Martinez‐Gamboa, L., Hofmann, M. C. J., Bonin, M., Arbach, O., Schendel, P., Gerlach, B., Hempel, K., Bespalov, A., Dirnagl, U., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0087-3 · Cited by 243
Chemical probes and drug leads from advances in synthetic planning and methodology
Gerry, C. J., & Schreiber, S. L. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.53 · Cited by 232
Self-citationStructure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
Martin, L. J., Koegl, M., Bader, G., Cockcroft, X. F., Fedorov, O., Fiegen, D., Gerstberger, T., Hofmann, M. H., Hohmann, A. F., Kessler, D., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01865 · Cited by 228
Self-citationLoss-of-function genetic tools for animal models: cross-species and cross-platform differences
Housden, B. E., Muhar, M., Gemberling, M. P., Gersbach, C. A., Stainier, D. Y. R., Seydoux, G., Mohr, S. E., Zuber, J. A., & Perrimon, N. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.118 · Cited by 225
A critical overview of computational approaches employed for COVID-19 drug discovery
Muratov, E. N., Amaro, R., Andrade, C. H., Brown, N., Ekins, S., Fourches, D., Isayev, O., Kozakov, D., Medina-Franco, J. L., Merz, K. M., et al. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01065k · Cited by 206
Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology
Blagg, J., & Workman, P. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.005 · Cited by 207
Self-citationInhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain
Akçay, G., Belmonte, M. A., Aquila, B., Chuaqui, C., Hird, A. W., Lamb, M. L., Rawlins, P. B., Su, N., Tentarelli, S., Grimster, N. P., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2174 · Cited by 207
Scaffold Diversity Synthesis and Its Application in Probe and Drug Discovery
García-Castro, M., Zimmermann, S., Sankar, M. G., & Kumar, K. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201508818 · Cited by 199
Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors
Romero, F. A., Taylor, A. M., Crawford, T. D., Tsui, V., Côté, A., & Magnuson, S. R. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01514 · Cited by 194
Applications of chemogenomic library screening in drug discovery
Jones, L. H., & Bunnage, M. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.244 · Cited by 192
Self-citationSensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
Hohmann, A. F., Martin, L. J., Minder, J. L., Roe, J., Shi, J., Steurer, S., Bader, G., McConnell, D. B., Pearson, M. A., Gerstberger, T., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2115 · Cited by 190
Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation
Zhang, T., Hatcher, J. M., Teng, M., Gray, N. S., & Kostic, M. (2019) · Cell Chemical Biology · doi:10.1016/j.chembiol.2019.09.012 · Cited by 178
Self-citationBAX, BAK, and BOK: A Coming of Age for the BCL-2 Family Effector ProteinsPreprint
Moldoveanu, T., & Czabotar, P. E. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a036319 · Cited by 197
Opportunities and challenges in translational science
Austin, C. P. (2021) · Clinical and Translational Science · doi:10.1111/cts.13055 · Cited by 188
Self-citationSoares, P., Gadd, M. S., Frost, J., Galdeano, C., Ellis, L. C. J., Epemolu, O., Rocha, S., Read, K. D., & Ciulli, A. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00675 · Cited by 182
The Ecstasy and Agony of Assay Interference Compounds
Aldrich, C. C., Bertozzi, C. R., Georg, G. I., Kiessling, L. L., Lindsley, C. W., Liotta, D. C., Merz, K. M., Schepartz, A., & Wang, S. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00229 · Cited by 180
The Symbiotic Relationship Between Drug Discovery and Organic Chemistry
Grygorenko, O. O., Volochnyuk, D. M., Ryabukhin, S. V., & Judd, D. B. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201903232 · Cited by 174
New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome
Wilson, L., Linley, A. J., Hammond, D. E., Hood, F. E., Coulson, J. M., MacEwan, D. J., Ross, S. J., Slupsky, J. R., Smith, P. D., Eyers, P. A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2291 · Cited by 178
Target 2035: probing the human proteome
Carter, A. J., Kraemer, O., Zwick, M., Mueller‐Fahrnow, A., Arrowsmith, C. H., & Edwards, A. M. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.06.020 · Cited by 164
Self-citationAlmqvist, H., Axelsson, H., Jafari, R., Chen, D., Mateus, A., Haraldsson, M., Larsson, A., Molina, D. M., Artursson, P., Lundbäck, T., et al. (2016) · Nature Communications · doi:10.1038/ncomms11040 · Cited by 165
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy
Wanior, M., Krämer, A., Knapp, S., & Joerger, A. C. (2021) · Oncogene · doi:10.1038/s41388-021-01781-x · Cited by 162
Self-citationChandrasekaran, S. N., Cimini, B. A., Goodale, A. B., Miller, L., Kost‐Alimova, M., Jamali, N., Doench, J. G., Fritchman, B., Skepner, A. P., Melanson, M., et al. (2024) · Nature Methods · doi:10.1038/s41592-024-02241-6 · Cited by 171
Design and characterization of bivalent BET inhibitors
Tanaka, M., Roberts, J. M., Seo, H., Souza, A., Paulk, J., Scott, T. G., DeAngelo, S. L., Dhe‐Paganon, S., & Bradner, J. E. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2209 · Cited by 160
The role of reversible and irreversible covalent chemistry in targeted protein degradation
Kiely‐Collins, H., Winter, G. E., & Bernardes, G. J. L. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.03.005 · Cited by 160
Tang, J. P., Tanoli, Z., Ravikumar, B., Alam, Z., Rebane, A., Vähä-Koskela, M. J. V., Peddinti, G., van Adrichem, A. J., Wakkinen, J., Jaiswal, A., et al. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.11.009 · Cited by 154
Self-citationRNA-modifying proteins as anticancer drug targets
Boriack‐Sjodin, P. A., Ribich, S. A., & Copeland, R. A. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.71 · Cited by 157
Self-citationProgress towards a public chemogenomic set for protein kinases and a call for contributions
Drewry, D. H., Wells, C. I., Andrews, D. M., Angell, R. M., Al‐Ali, H., Axtman, A. D., Capuzzi, S. J., Elkins, J. M., Ettmayer, P., Frederiksen, M. U., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181585 · Cited by 154
Self-citationBerginski, M. E., Moret, N., Liu, C., Goldfarb, D., Sorger, P. K., & Gomez, S. M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa853 · Cited by 144
Activity-Based Sensing for Site-Specific Proteomic Analysis of Cysteine Oxidation
Shi, Y., & Carroll, K. S. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00562 · Cited by 146
Targeting the Small GTPase Superfamily through Their Regulatory Proteins
Gray, J. L., von Delft, F., & Brennan, P. E. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201900585 · Cited by 148
Self-citationOligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells
Sambrooks, C. L., Shrimal, S., Khodier, C., Flaherty, D. P., Rinis, N., Charest, J. C., Gao, N., Zhao, P., Wells, L., Lewis, T. A., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2194 · Cited by 138
Exploring and Understanding the Biochemical Diversity of the Human Microbiota
Koppel, N., & Balskus, E. P. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2015.12.008 · Cited by 140
A chemical biology toolbox to study protein methyltransferases and epigenetic signaling
Scheer, S., Ackloo, S. Z., Medina, T. D. S., Schapira, M., Li, F., Ward, J. A., Lewis, A. M., Northrop, J. P., Richardson, P. L., Kanıskan, H. Ü., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07905-4 · Cited by 131
Self-citationChemoproteomics and Chemical Probes for Target Discovery
Drewes, G., & Knapp, S. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.06.008 · Cited by 132
Self-citationPotent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival
Kettle, J. G., Alwan, H. A. J., Biśta, M., Breed, J., Davies, N. L., Eckersley, K., Fillery, S. M., Foote, K. M., Goodwin, L., Jones, D. R., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01760 · Cited by 132
An αv‐RGD Integrin Inhibitor Toolbox: Drug Discovery Insight, Challenges and Opportunities
Hatley, R. J. D., Macdonald, S. J. F., Slack, R. J., Le, J., Ludbrook, S. B., & Lukey, P. T. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201707948 · Cited by 132
Potent and selective bivalent inhibitors of BET bromodomains
Waring, M. J., Chen, H., Rabow, A. A., Walker, G. E., Bobby, R., Boiko, S., Bradbury, R. H., Callis, R. J., Clark, E. A., Dale, I. L., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2210 · Cited by 132
Small Molecule Inhibitors of Protein Arginine Methyltransferases
Hu, H., Qian, K., Ho, M., & Zheng, Y. G. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1144747 · Cited by 129
Genotoxicity testing: progress and prospects for the next decade
Türkez, H., Arslan, M. E., & Tozlu, Ö. Ö. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1375097 · Cited by 128
Structure-based drug design: aiming for a perfect fit
van Montfort, R. L. M., & Workman, P. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170052 · Cited by 127
Self-citationA chemical toolbox for the study of bromodomains and epigenetic signaling
Wu, Q., Heidenreich, D. J., Zhou, S., Ackloo, S. Z., Krämer, A., Nakka, K. K., Lima‐Fernandes, E., Deblois, G., Duan, S., Vellanki, R. N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09672-2 · Cited by 124
Self-citationNon-kinase targets of protein kinase inhibitors
Munoz, L. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.266 · Cited by 123
Li, X., Zhang, B., Yan, C., Li, J., Wang, S., Wei, X., Jiang, X., Zhou, P., & Fang, J. (2019) · Nature Communications · doi:10.1038/s41467-019-10807-8 · Cited by 124
Protein S-Glyco-Modification through an Elimination–Addition Mechanism
Qin, K., Zhang, H., Zhao, Z., & Chen, X. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c02110 · Cited by 122
canSAR: update to the cancer translational research and drug discovery knowledgebase
Coker, E. A., Mitsopoulos, C., Tym, J. E., Komianou, A., Kannas, C. C., Micco, P. D., Villasclaras-Fernández, E. D., Özer, B., Antolín, A. A., Workman, P., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1129 · Cited by 121
Self-citationTranscription Factor Inhibition: Lessons Learned and Emerging Targets
Chen, A. W., & Koehler, A. N. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.004 · Cited by 123
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
Page, B. D. G., Valerie, N. C. K., Wright, R. H. G., Wallner, O. A., Isaksson, R., Carter, M., Rudd, S. G., Loseva, O., Jemth, A., Almlöf, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02293-7 · Cited by 123
Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target
Lechner, S., Malgapo, M. I. P., Grätz, C., Steimbach, R. R., Baron, A., Rüther, P. L., Nadal, S., Stumpf, C., Loos, C., Ku, X., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01015-5 · Cited by 121
Gerstenberger, B. S., Trzupek, J. D., Tallant, C., Fedorov, O., Filippakopoulos, P., Brennan, P. E., Fedele, V., Martin, S., Picaud, S., Rogers, C. M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00012 · Cited by 113
Self-citationProteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities
Harding, R., & Tong, Y. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2018.11 · Cited by 114
Irreproducibility in Preclinical Biomedical Research: Perceptions, Uncertainties, and Knowledge Gaps
Jarvis, M. F., & Williams, M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.12.001 · Cited by 129
Chemical Biology Probes from Advanced DNA-encoded Libraries
Salamon, H., Škopić, M. K., Jung, K., Bugain, O., & Brunschweiger, A. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00981 · Cited by 111
Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors
Dahlin, J. L., Nelson, K. M., Strasser, J. M., Baršytė-Lovejoy, D., Szewczyk, M. M., Organ, S. L., Cuellar, M. E., Singh, G., Shrimp, J. H., Nguyen, N. H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01657-3 · Cited by 109
Self-citationA chemical probe targeting the PWWP domain alters NSD2 nucleolar localization
Dilworth, D., Hanley, R. P., de Freitas, R. F., Allali‐Hassani, A., Zhou, M., Mehta, N., Marunde, M. R., Ackloo, S. Z., Machado, R. A. C., Yazdi, A. K., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00898-0 · Cited by 114
Self-citationExpanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes
Hartung, I. V., Rudolph, J., Mader, M. M., Mulder, M. P. C., & Workman, P. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00550 · Cited by 105
Self-citationDonated chemical probes for open science
Müller, S., Ackloo, S. Z., Arrowsmith, C. H., Bauser, M., Baryza, J. L., Blagg, J., Böttcher, J., Bountra, C., Brown, P. J., Bunnage, M. E., et al. (2018) · eLife · doi:10.7554/elife.34311 · Cited by 107
Self-citationThe Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification
Wells, C. I., Al‐Ali, H., Andrews, D. M., Asquith, C. R. M., Axtman, A. D., Chung, M., Đikić, I., Ebner, D. V., Elkins, J. M., Ettmayer, P., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020566 · Cited by 107
Self-citationThe emerging role of lysine methyltransferase SETD8 in human diseases
Milite, C., Feoli, A., Viviano, M., Rescigno, D., Cianciulli, A., Balzano, A. L., Mai, A., Castellano, S., & Sbardella, G. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0268-4 · Cited by 105
Extracellular vesicle drug occupancy enables real-time monitoring of targeted cancer therapy
Pan, S., Zhang, Y., Natalia, A., Lim, C. Z. J., Ho, N. R. Y., Chowbay, B., Loh, T. P., Tam, J. K. C., & Shao, H. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00872-w · Cited by 103
Badapple: promiscuity patterns from noisy evidence
Yang, J. J., Ursu, O., Lipinski, C. A., Sklar, L. A., Oprea, T. I., & Bologa, C. G. (2016) · Journal of Cheminformatics · doi:10.1186/s13321-016-0137-3 · Cited by 103
Nonparametric Analysis of Thermal Proteome Profiles Reveals Novel Drug-binding Proteins*
Childs, D., Bach, K., Franken, H., Anders, S., Kurzawa, N., Bantscheff, M., Savitski, M. M., & Huber, W. K. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir119.001481 · Cited by 103
Humphreys, P. G., Bamborough, P., Chung, C., Craggs, P. D., Gordon, L. J., Grandi, P., Hayhow, T. G., Hussain, J., Jones, K. L., Lindon, M. J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01566 · Cited by 100
Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor
Thomson, D. W., Poeckel, D., Zinn, N., Rau, C., Strohmer, K., Wagner, A. J., Graves, A. P., Perrin, J., Bantscheff, M., Duempelfeld, B., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00027 · Cited by 103
Dual action antifungal small molecule modulates multidrug efflux and TOR signaling
Shekhar-Guturja, T., Gunaherath, G. M. K. B., Wijeratne, E. M. K., Lambert, J.-P., Averette, A. F., Lee, S. C., Kim, T., Bahn, Y.-S., Tripodi, F., Ammar, R., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2165 · Cited by 101
A Cell Biologist’s Field Guide to Aurora Kinase Inhibitors
Groot, C. O. D., Hsia, J. E., Anzola, J. V., Motamedi, A., Yoon, M., Wong, Y. L., Jenkins, D., Lee, H. J., Martinez, M. B., Davis, R. L., et al. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00285 · Cited by 101
Medicinal chemistry in drug discovery in big pharma: past, present and future
Campbell, I. B., Macdonald, S. J. F., & Procopiou, P. A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.10.007 · Cited by 105
Metadata
- Authors
- Arrowsmith, C. H., Audia, J. E., Austin, C., Baell, J., Bennett, J., Blagg, J., Bountra, C., Brennan, P. E., Brown, P. J., Bunnage, M. E., Buser-Doepner, C., Campbell, R. M., Carter, A. J., Cohen, P., Copeland, R. A., Cravatt, B., Dahlin, J. L., Dhanak, D., Edwards, A. M., Frederiksen, M., Frye, S. V., Gray, N., Grimshaw, C. E., Hepworth, D., Howe, T., Huber, K. V. M., Jin, J., Knapp, S., Kotz, J. D., Kruger, R. G., Lowe, D., Mader, M. M., Marsden, B., Mueller-Fahrnow, A., Müller, S., O'Hagan, R. C., Overington, J. P., Owen, D. R., Rosenberg, S. H., Ross, R., Roth, B., Schapira, M., Schreiber, S. L., Shoichet, B., Sundström, M., Superti-Furga, G., Taunton, J., Toledo-Sherman, L., Walpole, C., Walters, M. A., Willson, T. M., Workman, P., Young, R. N., & Zuercher, W. J.
- Affiliations
- University of Toronto (CA)
- Constellation Pharmaceuticals (United States) (US)
- National Institutes of Health (US)
- Monash University (AU)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Institute of Cancer Research (GB)
- University of Oxford (GB)
- Structural Genomics Consortium (CA)
- Pfizer (United States) (US)
- Eli Lilly (United States) (US)
- Boehringer Ingelheim (Germany) (DE)
- University of Dundee (GB)
- Epizyme (United States) (US)
- Scripps Research Institute (US)
- Mayo Clinic (US)
- Novartis (Switzerland) (CH)
- University of North Carolina at Chapel Hill (US)
- Harvard University (US)
- Janssen (United Kingdom) (GB)
- Austrian Academy of Sciences (AT)
- Icahn School of Medicine at Mount Sinai (US)
- Broad Institute (US)
- GlaxoSmithKline (United States) (US)
- Vertex Pharmaceuticals (United States) (US)
- European Bioinformatics Institute (GB)
- AbbVie (United States) (US)
- University of California, San Francisco (US)
- Karolinska University Hospital (SE)
- Howard Hughes Medical Institute (US)
- University of Minnesota (US)
- Simon Fraser University (CA)
- Corresponding author
- Edwards, Aled M
- ORCID
- Arrowsmith, Cheryl H
- Audia, James E
- Austin, Christopher
- Baell, Jonathan
- Blagg, Julian
- Bountra, Chas
- Brennan, Paul E
- Brown, Peter J
- Bunnage, Mark E
- Campbell, Robert M
- Carter, Adrian J
- Cohen, Philip
- Copeland, Robert A
- Dahlin, Jayme L
- Edwards, Aled M
- Frederiksen, Mathias
- Frye, Stephen V
- Gray, Nathanael
- Grimshaw, Charles E
- Hepworth, David
- Huber, Kilian V M
- Jin, Jian
- Knapp, Stefan
- Kotz, Joanne D
- Mader, Mary M
- Marsden, Brian
- Müller, Susanne
- Overington, John P
- Owen, Dafydd R
- Ross, Ruth
- Roth, Bryan
- Schapira, Matthieu
- Schreiber, Stuart L
- Shoichet, Brian
- Sundström, Michael
- Taunton, Jack
- Walters, Michael A
- Willson, Timothy M
- Workman, Paul
- Young, Robert N
- Zuercher, William J
- Venue
- Nature Chemical Biology
- Published
- 2015-07-21
- Volume
- 11
- Issue
- 8
- Pages
- 536-541
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- PMC
- PMC4706458
- OpenAlex
- W1516646538
- Cited by
- 839
- References
- 41
- Citations by year
- 2026: 37 · 2025: 57 · 2024: 62 · 2023: 67 · 2022: 67 · 2021: 81 · 2020: 86 · 2019: 75 · 2018: 79 · 2017: 98 · 2016: 103 · 2015: 25
- FWCI
- 48.56
- Type
- journal article
- Language
- en
- Update notices
- erratum (2015-10-20)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Chemical Biology (publishedVersion, other-oa)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion, other-oa)
- Deakin Research Online (Deakin University) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- UNC Libraries
- Funders
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Harvard University
- University of Dundee
- Wellcome Trust (106169/Z/14/Z, 104104, 106169, 104104/A/14/Z, 100294)
- Constellation Pharmaceuticals
- Cancer Research UK (11566)
- University of Oxford
- Monash University
- Österreichischen Akademie der Wissenschaften
- University of Toronto
- National Institutes of Health
- University of North Carolina at Chapel Hill
- Novartis Institutes for BioMedical Research
- Medical Research Council (MR/K000985/1)
- National Institute of General Medical Sciences (R01GM103893)
- Janssen Research and Development
- National Center for Advancing Translational Sciences
- UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- chemical probes, best practices, wikis, research reproducibility, chemical biology
- MeSH terms
- Humans, Molecular Weight, Sensitivity and Specificity, Molecular Probes, Intellectual Property, Internet, Information Dissemination, Biomedical Research, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
